Thunder Bay Regional Health Sciences Centre is an acute care facility serving Thunder Bay and much of Northwestern Ontario, Canada. The hospital has 395 acute care beds.

There are 395 beds in Northwestern Ontario Regional Cancer Centre, Thunder Bay.

During the past decade, Northwestern Ontario Regional Cancer Centre, Thunder Bay conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwestern Ontario Regional Cancer Centre, Thunder Bay" #1 sponsor was "Radiation Therapy Oncology Group" with 42 trials, followed by "NCIC Clinical Trials Group" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern Ontario Regional Cancer Centre, Thunder Bay" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern Ontario Regional Cancer Centre, Thunder Bay" are "Breast Cancer" (13 trials), "Prostate Cancer" (12 trials), "Lung Cancer" (10 trials), "Head and Neck Cancer" (9 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "Northwestern Ontario Regional Cancer Centre, Thunder Bay" in a lesser frequency.

Most popular intervention types in "Northwestern Ontario Regional Cancer Centre, Thunder Bay" are "Drug" (57 trials), "Radiation" (44 trials), "Procedure" (23 trials), "Biological" (12 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (33 trials), "cisplatin" (10 trials), "conventional surgery" (9 trials), "paclitaxel" (8 trials) and "quality-of-life assessment" (8 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Ontario Regional Cancer Centre, Thunder Bay" are 55 trials for "All" genders, 15 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Northwestern Ontario Regional Cancer Centre, Thunder Bay". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Northwestern Ontario Regional Cancer Centre, Thunder Bay, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Ontario Regional Cancer Centre, Thunder Bay, 8 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".